Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression [Phase 2]
Phase 2 clinical trial update on a single IV dose of GLYX-13 (Rapastinel) for treatment-resistant major depressive disorder; study completed…
-
FDA approval · 2012-09-12FDA Approved: ESCITALOPRAM — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals' original application for escitalopram oxalate, granting approval of a generic escitalopram pr…
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM OXALATE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approves Quallent Pharmaceuticals Health LLC's original application for escitalopram oxalate as a generic antidepressant indicated for m…
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM — Original Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare Inc.'s original application for generic escitalopram, expanding availability of the antidepressant.
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM OXALATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's original application for escitalopram oxalate, a generic antidepressant, providing a generic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic escitalopram (escitalopram) under an Original Application, for its approved indications in major…
-
CLINICAL_TRIALS research · 2012-09-11Clinical Trial Update: The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression
This clinical trial update reports on the investigation of Fer-01 (Soline) for its antidepressant properties and safety in patients with maj…
-
CLINICAL_TRIALS research · 2012-09-11Clinical Trial Update: Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder
This update reports on the incidence of metabolic syndrome and thyroid dysfunction among patients with major depressive disorder.
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM — Original Application (Rising Pharma Holdings, Inc.)
FDA approves an original-application ANDA for escitalopram from Rising Pharma Holdings, enabling a generic version of the antidepressant. Th…
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM OXALATE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved the original application for escitalopram oxalate as a generic product, manufactured by Exelan Pharmaceuticals Inc., to treat m…
-
FDA approval · 2012-09-11FDA Approved: ESCITALOPRAM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for escitalopram oxalate by Aurobindo Pharma Limited, enabling a generic version of escitalopram. The …
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Special Investigation Of Long Term Use Of Sertraline.
A completed clinical trial update investigating long-term sertraline use, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Evaluating the Effectiveness of Brief Interpersonal Psychotherapy for Pregnant Women With Depression [NA]
This clinical trial update indicates that the study assessing Brief Interpersonal Psychotherapy for pregnant women with depression has compl…
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence [Phase 2]
This Phase 2 clinical trial evaluated fluoxetine in youths with co-occurring major depressive disorder and cannabis use disorder. The result…
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)
Pfizer-sponsored clinical trial in Major Depressive Disorder reports remission-rate outcomes; results were posted on 2012-08-31.
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Effects of an Integrative Treatment Model to Reduce Anxiety and Depression in Minor Mental Health Problems and Medically Unexplained Symptoms [NA]
This clinical trial update reports completion of a study evaluating an integrative treatment model to reduce anxiety and depression in indiv…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Measuring Quality of Decisions About Treatment of Depression [NA]
A completed clinical trial update reporting results of a study that measured the quality of decisions in treating depression.
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Safety Study of F2695 SR in Major Depressive Disorder [Phase 3]
A Phase 3 safety study of F2695 SR in adults with Major depressive disorder has completed; the snippet does not include the trial results.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Rapid Antidepressant Effects of Yohimbine in Major Depression [Phase 2]
A Phase 2 trial investigated rapid antidepressant effects of yohimbine in major depression, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Major Depressive Disorder (MDD)
A clinical trial focusing on major depressive disorder sponsored by Eli Lilly has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Beat the Blues: Treating Depression in African American Elders [Phase 3]
Phase 3 clinical trial evaluating Beat the Blues, a behavioral activation treatment for depression in African American elders, has completed…
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: D-cycloserine for Major Depressive Disorder [Phase 2]
A Phase 2 clinical trial of D-cycloserine for Major Depressive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Sinusitis and Facial Pain Disorders Anti-Depression Trial [Phase 4]
A Phase 4 trial evaluating an antidepressant for chronic sinusitis and facial pain disorders was terminated, with results posted in 2012. Th…
-
FDA approval · 2012-08-02FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) from Bausch Health US LLC, likely resulting in a lab…
-
FDA approval · 2012-08-02FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC.